Post Marketing Surveillance Study of Dysport

Ipsen783 enrolled

Overview

The purpose of this study is to provide further information regarding the risks and benefits of Dysport in marketed indications.

Study Type

OBSERVATIONAL

Enrollment

783

Conditions

Blepharospasm Hemifacial Spasm Cervical Dystonia Spasmodic Torticollis Cerebral Palsy Muscle Spasticity Cerebrovascular Accident Equinus Deformity Facial Hyperdynamic Lines

Eligibility

Sex: ALLMin age: 2 Years

Medical Language ↔ Plain English

Inclusion Criteria: * adult or child over the age of 2 years * scheduled to receive Dysport as per their normal treatment practice, and in conformance with their country's Summary of Product Characteristics Exclusion Criteria: * history of hypersensitivity to Dysport or drugs with a similar chemical structure * treatment with any other investigational drug within the last 30 days before survey entry

Locations (36)

Outcomes

Primary Outcomes

- assessment of efficacy as assessed by treating physician at scheduled follow up visit

- data on adverse events since treatment with Dysport

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Centre Hospitalier Saint Esprit

Agen, France

Center Hospitalier du Pays d'Aix

Aix-en-Provence, France

Centre Hospitalier

Chambéry, France

Hopital Timone Adultes

Marseille, France

Hopital Central

Nancy, France

Hopital Hotel Dieu

Nantes, France

Hopital Pasteur

Nice, France

Hopital Caremeau

Nîmes, France

Hopital Saint Antione

Paris, France

Centre Hospitalier Pitie Salpetriere

Paris, France

...and 26 more locations